Nikko Asset Management Americas’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-850,035
| Closed | -$56.8M | – | 187 |
|
|
2024
Q3 | $56.8M | Buy |
850,035
+148,986
| +21% | +$9.96M | 0.64% | 40 |
|
|
2024
Q2 | $83.2M | Sell |
701,049
-40,734
| -5% | -$4.84M | 0.96% | 28 |
|
|
2024
Q1 | $79M | Buy |
741,783
+453,004
| +157% | +$48.3M | 0.78% | 35 |
|
|
2023
Q4 | $28.7M | Buy |
288,779
+163,607
| +131% | +$16.3M | 0.28% | 60 |
|
|
2023
Q3 | $12.9M | Buy |
125,172
+102,285
| +447% | +$10.6M | 0.15% | 76 |
|
|
2023
Q2 | $2.78M | Buy |
22,887
+901
| +4% | +$109K | 0.03% | 135 |
|
|
2023
Q1 | $3.34M | Sell |
21,986
-1,624
| -7% | -$247K | 0.04% | 125 |
|
|
2022
Q4 | $4.24M | Sell |
23,610
-1,776
| -7% | -$319K | 0.06% | 121 |
|
|
2022
Q3 | $3.01M | Buy |
25,386
+96
| +0.4% | +$11.4K | 0.04% | 133 |
|
|
2022
Q2 | $3.59M | Buy |
+25,290
| New | +$3.59M | 0.04% | 132 |
|